Yoshiko Mori

  • 106 Citations
  • 4 h-Index
20092019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Yoshiko Mori is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 46 Similar Profiles
Colorectal Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Mutation Medicine & Life Sciences
irinotecan Medicine & Life Sciences
Rectal Neoplasms Medicine & Life Sciences
Microsatellite Instability Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2009 2019

  • 106 Citations
  • 4 h-Index
  • 25 Article
  • 1 Chapter
2 Citations (Scopus)

Activation of AZIN1 RNA editing is a novel mechanism that promotes invasive potential of cancer-associated fibroblasts in colorectal cancer

Takeda, S., Shigeyasu, K., Okugawa, Y., Yoshida, K., Mori, Y., Yano, S., Noma, K., Umeda, Y., Kondo, Y., Kishimoto, H., Teranishi, F., Nagasaka, T., Tazawa, H., Kagawa, S., Fujiwara, T. & Goel, A., Mar 1 2019, In : Cancer Letters. 444, p. 127-135 9 p.

Research output: Contribution to journalArticle

RNA Editing
Colorectal Neoplasms
Fibroblasts
Tumor Microenvironment
Neoplasms

Multicenter phase II study of biweekly CAPIRI plus bevacizumab as second-line therapy in patients with metastatic colorectal cancer (JSWOG-C3 study)

Suzuki, N., Hazama, S., Nagasaka, T., Tanioka, H., Iwamoto, Y., Negoro, Y., Yamauchi, M., Kobayashi, M., Okuda, H., Fujishima, N., Nishimura, T., Yamanaka, N., Toyota, K., Mori, Y., Nakagami, Y., Shimokawa, M., Nagano, H. & Okajima, M., Jan 1 2019, In : International Journal of Clinical Oncology.

Research output: Contribution to journalArticle

Open Access
irinotecan
Colorectal Neoplasms
Confidence Intervals
oxaliplatin
Drug Therapy
4 Citations (Scopus)

Accuracy of four mononucleotide-repeat markers for the identification of DNA mismatch-repair deficiency in solid tumors

Takehara, Y., Nagasaka, T., Nyuya, A., Haruma, T., Haraga, J., Mori, Y., Nakamura, K., Fujiwara, T., Boland, C. R. & Goel, A., Jan 12 2018, In : Journal of Translational Medicine. 16, 1, 5.

Research output: Contribution to journalArticle

DNA Repair-Deficiency Disorders
DNA Mismatch Repair
Tumors
Repair
DNA
2 Citations (Scopus)

BRAF V600E mutation is a predictive indicator of upfront chemotherapy for stage IV colorectal cancer

Morikawa, T., Inada, R., Nagasaka, T., Mori, Y., Kishimoto, H., Kawai, T., Umeda, Y., Mishima, H., Goel, A. & Fujiwara, T., Feb 1 2018, In : Oncology Letters. 15, 2, p. 2195-2201 7 p.

Research output: Contribution to journalArticle

Colorectal Neoplasms
Drug Therapy
Mutation
Exons
Neoplasms

Clinical outcomes of women with ovarian metastases of colorectal cancer treated with oophorectomy with respect to their somatic mutation profiles

Mori, Y., Nyuya, A., Yasui, K., Toshima, T., Kawai, T., Taniguchi, F., Kimura, K., Inada, R., Nishizaki, M., Haraga, J., Nakamura, K., Umeda, Y., Kishimoto, H., Fujiwara, T., Katata, Y., Yamaguchi, Y. & Nagasaka, T., Jan 1 2018, In : Oncotarget. 9, 23, p. 16477-16488 12 p.

Research output: Contribution to journalArticle

Ovariectomy
Colorectal Neoplasms
Neoplasm Metastasis
Mutation
Survival